Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KOSTAIVE study: Safety and immunogenicity of Kostaive COVID-19 vaccine in the elderly
jRCTs021250024Active, not recruiting
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fostamatinib in coronavirus disease 2019 (COVID-19), sponsored by Ministry of Health, Labour and Welfare. Primary endpoint: Specific and unspecified adverse events through Day 29. Started Dec 2025; status: active, not recruiting.
02
Drugs
fostamatinib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCTs021250024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021250024.